Increasing Uptake of EHR-enabled Population Health Outreach Strategies to Improve Diabetes Screening (NCT05730582) | Clinical Trial Compass
By InvitationNot Applicable
Increasing Uptake of EHR-enabled Population Health Outreach Strategies to Improve Diabetes Screening
United States500,000 participantsStarted 2024-03-05
Plain-language summary
The study team's central hypothesis is that the Parkland Diabetes Detection Program (PDDP) screening invitations targeted by race/ethnicity with culturally concordant messaging and tailored by glycemic risk (known PDM vs. unknown glycemic state) plus phone-based navigation of non-responders will be more effective at closing screening gaps than PDDP generic screening invitations and usual care, opportunistic screening alone.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient is alive at time of data extraction
* Age \>= 18 at time of data extraction and \<76
* Visit with PCP at Parkland clinic in the last 18 months (548 days), where Encounter type = Virtual Visit or Encounter type = Office Visit
* Patient NOT included in Parkland Diabetes Registry
* Preferred language is Spanish or English
* Ethnicity is Hispanic or Non-Hispanic
* Race is White or Black
* Patient is not pregnant in last 12 months
Exclusion Criteria for Study Population 1: Prediabetes Glycemic Risk Group
* Last A1C value \<5.7 (normal)
* Last A1C value \>6.4 (diabetes)
* Last A1C value = blank (unchecked)
* Last A1C date occurred within last 12 months from date of export
Exclusion Criteria for Study Population 2: Score-Based Glycemic Risk Group
* Risk score \<9
* Last A1C date occurred in last 30 months from date of export
* Last A1C value was \>5.7 (PDM/DM)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Invitation efficacy
Timeframe: 60 days
2
Program effectiveness
Timeframe: 12 months
3
Direct costs
Timeframe: 12 months
4
Cost effectiveness as measured by costs per patient screened
Timeframe: 12 months
5
Cost effectiveness as measured by cost per case found
Timeframe: 12 months
Trial details
NCT IDNCT05730582
SponsorUniversity of Texas Southwestern Medical Center